ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 73.19

Change

-0.65 (-0.88)%

Market Cap

CAD 0.28B

Volume

5.01K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.11 (-0.28%)

CAD 2.84B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.68%)

CAD 1.93B
XHC:CA iShares Global Healthcare (CAD..

-0.48 (-0.63%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

-0.03 (-0.14%)

CAD 0.64B
XIT:CA iShares S&P/TSX Capped Informa..

-0.32 (-0.56%)

CAD 0.63B
HTA:CA Harvest Tech Achievers Growth ..

N/A

CAD 0.61B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.19 (+0.87%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.59 (-0.99%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.09 (+0.32%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.98 (-1.55%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.30% 20% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.30% 20% F 34% F
Trailing 12 Months  
Capital Gain 12.39% 37% F 44% F
Dividend Return 0.78% 27% F 17% F
Total Return 13.17% 31% F 41% F
Trailing 5 Years  
Capital Gain 36.37% 40% F 64% D
Dividend Return 2.19% 16% F 9% A-
Total Return 38.56% 29% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 4.98% 29% F 56% F
Dividend Return 5.35% 26% F 53% F
Total Return 0.37% 28% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 16.70% 60% D- 50% F
Risk Adjusted Return 32.05% 29% F 51% F
Market Capitalization 0.28B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.